Guanosine 5'-triphosphate 2'(3')-diphosphate. A guanine nucleotide containing five phosphate groups. Three phosphate groups are esterified to the sugar moiety in the 5' position and the other two in the 2' or 3' position. This nucleotide serves as a messenger to turn off the synthesis of ribosomal RNA when amino acids are not available for protein synthesis. Synonym: magic spot II.
An actinomycete from which the antibiotic OLEANDOMYCIN is obtained.
Guanosine 5'-diphosphate 2'(3')-diphosphate. A guanine nucleotide containing four phosphate groups. Two phosphate groups are esterified to the sugar moiety in the 5' position and the other two in the 2' or 3' position. This nucleotide serves as a messenger to turn off the synthesis of ribosomal RNA when amino acids are not available for protein synthesis. Synonym: magic spot I.
A group of compounds which consist of a nucleotide molecule to which an additional nucleoside is attached through the phosphate molecule(s). The nucleotide can contain any number of phosphates.
A class of enzymes that catalyze the formation of a bond between two substrate molecules, coupled with the hydrolysis of a pyrophosphate bond in ATP or a similar energy donor. (Dorland, 28th ed) EC 6.
A purine nucleoside that has guanine linked by its N9 nitrogen to the C1 carbon of ribose. It is a component of ribonucleic acid and its nucleotides play important roles in metabolism. (From Dorland, 28th ed)
An enzyme that catalyzes the phosphorylation of AMP to ADP in the presence of ATP or inorganic triphosphate. EC 2.7.4.3.
The method of measuring the dispersion of an optically active molecule to determine the relative magnitude of right- or left-handed components and sometimes structural features of the molecule.
A compound that, along with its isomer, Cleland's reagent (DITHIOTHREITOL), is used for the protection of sulfhydryl groups against oxidation to disulfides and for the reduction of disulfides to sulfhydryl groups.
Guanine nucleotides are cyclic or linear molecules that consist of a guanine base, a pentose sugar (ribose in the cyclic form, deoxyribose in the linear form), and one or more phosphate groups, playing crucial roles in signal transduction, protein synthesis, and regulation of enzymatic activities.
A subclass of purinergic P2 receptors that signal by means of a ligand-gated ion channel. They are comprised of three P2X subunits which can be identical (homotrimeric form) or dissimilar (heterotrimeric form).
Adenine nucleotides are molecules that consist of an adenine base attached to a ribose sugar and one, two, or three phosphate groups, including adenosine monophosphate (AMP), adenosine diphosphate (ADP), and adenosine triphosphate (ATP), which play crucial roles in energy transfer and signaling processes within cells.
An enzyme that catalyzes reversible reactions of a nucleoside triphosphate, e.g., ATP, with a nucleoside monophosphate, e.g., UMP, to form ADP and UDP. Many nucleoside monophosphates can act as acceptor while many ribo- and deoxyribonucleoside triphosphates can act as donor. EC 2.7.4.4.
A rather large group of enzymes comprising not only those transferring phosphate but also diphosphate, nucleotidyl residues, and others. These have also been subdivided according to the acceptor group. (From Enzyme Nomenclature, 1992) EC 2.7.
A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties.
Guanosine 5'-(trihydrogen diphosphate), monoanhydride with phosphorothioic acid. A stable GTP analog which enjoys a variety of physiological actions such as stimulation of guanine nucleotide-binding proteins, phosphoinositide hydrolysis, cyclic AMP accumulation, and activation of specific proto-oncogenes.
A class of cell surface receptors for PURINES that prefer ATP or ADP over ADENOSINE. P2 purinergic receptors are widespread in the periphery and in the central and peripheral nervous system.
Guanosine 5'-(tetrahydrogen triphosphate). A guanine nucleotide containing three phosphate groups esterified to the sugar moiety.
An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter.

Thiostrepton-resistant mutants exhibit relaxed synthesis of RNA. (1/85)

Spontaneous mutants of Bacillus subtilis resistant to thiostrepton (TSP) exhibit relaxed synthesis of RNA when starved for required amino acids. Intact cells of tsp mutants cannot synthesize the regulatory nucleotides, ppGpp and pppGpp, after amino acid deprivation. Because ribosomes isolated from spontaneous revertants to thiostrepton sensitivity and from wild-type stringent strains can synthesize (p)ppGpp whereas ribosomes isolated from tsp strains cannot synthesize these regulatory nucleotides in the presence of stringent factor, it appears that the lesion is expressed at the level of the ribosome. Genetic mapping, via three-factor transformational crosses, has shown that tsp is closely linked to rif, in the order cysA14, tsp, rif-I, strA. The phenotype of the tsp mutants indicates that they are of the relC type. Their map position indicates that they are different from a previously described B subtilis rel mutation. Ribosomes from the latter strain can synthesize (p)ppGpp in cell-free extracts.  (+info)

The stringent response in Myxococcus xanthus is regulated by SocE and the CsgA C-signaling protein. (2/85)

Myxococcus xanthus fruiting body development is induced by amino acid limitation. The decision to grow or develop is established by the RelA-dependent stringent response and A-signaling. We identified two new members of this regulatory hierarchy, socE and the C-signaling gene csgA. SocE depletion arrests growth and induces sporulation under conditions that normally favor growth as well as curtailing DNA and stable RNA synthesis, inhibiting cell elongation, and inducing accumulations of the stringent nucleotides ppGpp and pppGpp [(p)ppGpp]. This system separates C-signaling, which does not occur under these conditions, from CsgA enzyme activity. Amino acid substitutions in the CsgA coenzyme binding pocket or catalytic site eliminate growth arrest. relA mutation also eliminates growth arrest. Eleven pseudorevertants selected for growth following SocE depletion contained mutations in csgA or relA. These results suggest that CsgA induces the stringent response and while SocE inhibits it. Unlike the csgA mutant, wild-type and socE csgA cells maintained high levels of (p)ppGpp throughout development. We suggest that CsgA maintains growth arrest throughout development to divert carbon from A-signaling and other sources into developmental macromolecular synthesis.  (+info)

Arabidopsis RelA/SpoT homologs implicate (p)ppGpp in plant signaling. (3/85)

Arabidopsis RPP5 is a member of a large class of pathogen resistance genes encoding nucleotide-binding sites and leucine-rich repeat domains. Yeast two-hybrid analysis showed that RPP5 specifically interacts with At-RSH1, an Arabidopsis RelA/SpoT homolog. In Escherichia coli, RelA and SpoT determine the level of guanosine tetraphosphate (ppGpp) and guanosine pentaphosphate (pppGpp), which are the effector nucleotides of the bacterial stringent response. Functional analysis in E. coli and in Streptomyces coelicolor A3 (2) showed that At-RSH1 confers phenotypes associated with (p)ppGpp synthesis. We characterized two additional Arabidopsis RelA/SpoT homologs, At-RSH2 and At-RSH3. At-RSH genes may regulate a rapid plant (p)ppGpp-mediated response to pathogens and other stresses.  (+info)

Modulation of RNA polymerase by (p)ppGpp reveals a RecG-dependent mechanism for replication fork progression. (4/85)

We have discovered a correlation between the ability of Escherichia coli cells to survive damage to DNA and their ability to modulate RNA polymerase via the stringent response regulators, (p)ppGpp. Elevation of (p)ppGpp, or certain mutations in the beta subunit of RNA polymerase, dramatically improve survival of UV-irradiated strains lacking the RuvABC Holliday junction resolvase. Increased survival depends on excision and recombination proteins and relies on the ability of RecG helicase to form Holliday junctions from replication forks stalled at lesions in the DNA and of PriA to initiate replication restart. The role of RecG provides novel insights into the interplay between transcription, replication, and recombination, and suggests a general model in which recombination underpins genome duplication in the face of frequent obstacles to replication fork progression.  (+info)

In vivo and in vitro effects of (p)ppGpp on the sigma(54) promoter Pu of the TOL plasmid of Pseudomonas putida. (5/85)

The connection between the physiological control of the sigma(54)-dependent Pu promoter of the TOL plasmid pWW0 of Pseudomonas putida and the stringent response mediated by the alarmone (p)ppGpp has been examined in vivo an in vitro. To this end, the key regulatory elements of the system were faithfully reproduced in an Escherichia coli strain and assayed as lacZ fusions in various genetic backgrounds lacking (p)ppGpp or overexpressing relA. Neither the responsiveness of Pu to 3-methyl benzylalcohol mediated by its cognate activator XylR nor the down-regulation of the promoter by rapid growth were affected in relA/spoT strains to an extent which could account for the known physiological control that governs this promoter. Overexpression of the relA gene [predicted to increase intracellullar (p)ppGpp levels] did, however, cause a significant gain in Pu activity. Since such a gain might be the result of indirect effects, we resorted to an in vitro transcription system to assay directly the effect of ppGpp on the transcriptional machinery. Although we did observe a significant increase in Pu performance through a range of sigma(54)-RNAP concentrations, such an increase never exceeded twofold. The difference between these results and the behavior of the related Po promoter of the phenol degradation plasmid pVI150 could be traced to the different promoter sequences, which may dictate the type of metabolic signals recruited for the physiological control of sigma(54)-systems.  (+info)

The stringent response of Mycobacterium tuberculosis is required for long-term survival. (6/85)

The stringent response utilizes hyperphosphorylated guanine [(p)ppGpp] as a signaling molecule to control bacterial gene expression involved in long-term survival under starvation conditions. In gram-negative bacteria, (p)ppGpp is produced by the activity of the related RelA and SpoT proteins. Mycobacterium tuberculosis contains a single homolog of these proteins (Rel(Mtb)) and responds to nutrient starvation by producing (p)ppGpp. A rel(Mtb) knockout strain was constructed in a virulent strain of M. tuberculosis, H37Rv, by allelic replacement. The rel(Mtb) mutant displayed a significantly slower aerobic growth rate than the wild type in synthetic liquid media, whether rich or minimal. The growth rate of the wild type was equivalent to that of the mutant when citrate or phospholipid was employed as the sole carbon source. These two organisms also showed identical growth rates within a human macrophage-like cell line. These results suggest that the in vivo carbon source does not represent a stressful condition for the bacilli, since it appears to be utilized in a similar Rel(Mtb)-independent manner. In vitro growth in liquid media represents a condition that benefits from Rel(Mtb)-mediated adaptation. Long-term survival of the rel(Mtb) mutant during in vitro starvation or nutrient run out in normal media was significantly impaired compared to that in the wild type. In addition, the mutant was significantly less able to survive extended anaerobic incubation than the wild-type virulent organism. Thus, the Rel(Mtb) protein is required for long-term survival of pathogenic mycobacteria under starvation conditions.  (+info)

Nucleoid proteins stimulate stringently controlled bacterial promoters: a link between the cAMP-CRP and the (p)ppGpp regulons in Escherichia coli. (7/85)

We report that the H-NS nucleoid protein plays a positive role in the expression of stringently regulated genes in Escherichia coli. Bacteria lacking both H-NS and the paralog StpA show reduced growth rate. Colonies displaying an increased growth rate were isolated, and mapping of a suppressor mutation revealed a base pair substitution in the spoT gene. The spoT(A404E) mutant showed low ppGpp synthesizing ability. The crp gene, which encodes the global regulator CRP, was subject to negative stringent regulation. The stable RNA/protein ratio in an hns, stpA strain was decreased, whereas it was restored in the suppressor strain. Our findings provide evidence of a direct link between the cAMP-CRP modulon and the stringent response.  (+info)

Regulation of Escherichia coli RelA requires oligomerization of the C-terminal domain. (8/85)

The E. coli RelA protein is a ribosome-dependent (p)ppGpp synthetase that is activated in response to amino acid starvation. RelA can be dissected both functionally and physically into two domains: The N-terminal domain (NTD) (amino acids [aa] 1 to 455) contains the catalytic domain of RelA, and the C-terminal domain (CTD) (aa 455 to 744) is involved in regulating RelA activity. We used mutational analysis to localize sites important for RelA activity and control in these two domains. We inserted two separate mutations into the NTD, which resulted in mutated RelA proteins that were impaired in their ability to synthesize (p)ppGpp. When we caused the CTD in relA(+) cells to be overexpressed, (p)ppGpp accumulation during amino acid starvation was negatively affected. Mutational analysis showed that Cys-612, Asp-637, and Cys-638, found in a conserved amino acid sequence (aa 612 to 638), are essential for this negative effect of the CTD. When mutations corresponding to these residues were inserted into the full-length relA gene, the mutated RelA proteins were impaired in their regulation. In attempting to clarify the mechanism through which the CTD regulates RelA activity, we found no evidence for competition for ribosomal binding between the normal RelA and the overexpressed CTD. Results from CyaA complementation experiments of the bacterial two-hybrid system fusion plasmids (G. Karimova, J. Pidoux, A. Ullmann, and D. Ladant, Proc. Natl. Acad. Sci. USA 95:5752-5756, 1998) indicated that the CTD (aa 564 to 744) is involved in RelA-RelA interactions. Our findings support a model in which RelA activation is regulated by its oligomerization state.  (+info)

Guanosine pentaphosphate (also known as P5G or GpppG) is not a commonly used medical term, but it is a molecule that plays a role in the biochemical processes of cells. It is a type of guanosine nucleotide, which is a compound made up of a sugar (ribose), a phosphate group, and a nitrogenous base (guanine).

In particular, guanosine pentaphosphate is a molecule that contains five phosphate groups attached to the ribose sugar. It functions as an activator of certain enzymes and is involved in various cellular processes, such as protein synthesis and signal transduction. However, it is not typically used as a diagnostic or clinical term in medicine.

"Streptomyces antibioticus" is not a medical term per se, but rather a scientific name used in microbiology and biochemistry. It refers to a specific species of bacteria belonging to the genus "Streptomyces," which are known for their ability to produce various antibiotics. The species "S. antibioticus" has been particularly important in the discovery and production of several clinically relevant antibiotics, such as neomycin and ribostamycin. These antibiotics have been used in medical treatments to target various bacterial infections. However, it is essential to note that the bacteria itself is not a medical condition or disease; instead, its products (antibiotics) are significant in medical contexts.

Guanosine tetraphosphate, also known as P1,P3-cyclic di-GMP or cdG, is a second messenger molecule that plays a role in the regulation of various cellular processes in bacteria and some plants. It is a cyclic compound consisting of two guanosine monophosphate (GMP) units linked by two phosphate groups.

This molecule is involved in the regulation of diverse bacterial functions, such as biofilm formation, motility, virulence, and stress response. The intracellular levels of c-di-GMP are controlled through the activity of enzymes called diguanylate cyclases (DGCs) and phosphodiesterases (PDEs). DGCs synthesize c-di-GMP from two GTP molecules, while PDEs degrade it into linear forms.

While guanosine tetraphosphate is not a common term in human or animal medicine, understanding its role in bacterial signaling and regulation can contribute to the development of novel strategies for controlling bacterial infections and other related applications.

Dinucleoside phosphates are the chemical compounds that result from the linkage of two nucleosides through a phosphate group. Nucleosides themselves consist of a sugar molecule (ribose or deoxyribose) and a nitrogenous base (adenine, guanine, cytosine, thymine, or uracil). When two nucleosides are joined together by an ester bond between the phosphate group and the 5'-hydroxyl group of the sugar moiety, they form a dinucleoside phosphate.

These compounds play crucial roles in various biological processes, particularly in the context of DNA and RNA synthesis and repair. For instance, dinucleoside phosphates serve as building blocks for the formation of longer nucleic acid chains during replication and transcription. They are also involved in signaling pathways and energy transfer within cells.

It is worth noting that the term "dinucleotides" is sometimes used interchangeably with dinucleoside phosphates, although technically, dinucleotides refer to compounds formed by joining two nucleotides (nucleosides plus one or more phosphate groups) rather than just two nucleosides.

Ligases are a group of enzymes that catalyze the formation of a covalent bond between two molecules, usually involving the joining of two nucleotides in a DNA or RNA strand. They play a crucial role in various biological processes such as DNA replication, repair, and recombination. In DNA ligases, the enzyme seals nicks or breaks in the phosphodiester backbone of the DNA molecule by catalyzing the formation of an ester bond between the 3'-hydroxyl group and the 5'-phosphate group of adjacent nucleotides. This process is essential for maintaining genomic integrity and stability.

Guanosine is a nucleoside that consists of a guanine base linked to a ribose sugar molecule through a beta-N9-glycosidic bond. It plays a crucial role in various biological processes, such as serving as a building block for DNA and RNA during replication and transcription. Guanosine triphosphate (GTP) and guanosine diphosphate (GDP) are important energy carriers and signaling molecules involved in intracellular regulation. Additionally, guanosine has been studied for its potential role as a neuroprotective agent and possible contribution to cell-to-cell communication.

Adenylate kinase is an enzyme (EC 2.7.4.3) that catalyzes the reversible transfer of a phosphate group between adenine nucleotides, specifically between ATP and AMP to form two ADP molecules. This reaction plays a crucial role in maintaining the energy charge of the cell by interconverting these important energy currency molecules.

The general reaction catalyzed by adenylate kinase is:

AMP + ATP ↔ 2ADP

This enzyme is widely distributed in various organisms and tissues, including mammalian cells. In humans, there are several isoforms of adenylate kinase, located in different cellular compartments such as the cytosol, mitochondria, and nucleus. These isoforms have distinct roles in maintaining energy homeostasis and protecting cells under stress conditions. Dysregulation of adenylate kinase activity has been implicated in several pathological processes, including neurodegenerative diseases, ischemia-reperfusion injury, and cancer.

Optical rotatory dispersion (ORD) is a phenomenon in which plane-polarized light is rotated as it passes through an optically active substance. It is a measure of the difference in refractive index between left and right circularly polarized light, and is dependent on the wavelength of the light. ORD is used to determine the optical purity and absolute configuration of chiral molecules, particularly in the field of stereochemistry. The magnitude and sign of the rotation can provide information about the concentration and type of optically active compound present in a sample.

Dithioerythritol is a chemical compound with the formula (HOCH₂)₂SS(CHOH)₂. It is a colorless, viscous liquid that is used as a reducing agent and antioxidant in various industrial and laboratory applications. In the medical field, it has been studied for its potential use as an anti-inflammatory and antiviral agent, although it is not currently approved for use as a drug. It may also be used as a reagent in diagnostic tests and as a solvent in pharmaceutical preparations.

Guanine nucleotides are molecules that play a crucial role in intracellular signaling, cellular regulation, and various biological processes within cells. They consist of a guanine base, a sugar (ribose or deoxyribose), and one or more phosphate groups. The most common guanine nucleotides are GDP (guanosine diphosphate) and GTP (guanosine triphosphate).

GTP is hydrolyzed to GDP and inorganic phosphate by certain enzymes called GTPases, releasing energy that drives various cellular functions such as protein synthesis, signal transduction, vesicle transport, and cell division. On the other hand, GDP can be rephosphorylated back to GTP by nucleotide diphosphate kinases, allowing for the recycling of these molecules within the cell.

In addition to their role in signaling and regulation, guanine nucleotides also serve as building blocks for RNA (ribonucleic acid) synthesis during transcription, where they pair with cytosine nucleotides via hydrogen bonds to form base pairs in the resulting RNA molecule.

Purinergic P2X receptors are a type of ligand-gated ion channel that are activated by the binding of extracellular ATP (adenosine triphosphate) and other purinergic agonists. These receptors play important roles in various physiological processes, including neurotransmission, pain perception, and immune response.

P2X receptors are composed of three subunits that form a functional ion channel. There are seven different subunits (P2X1-7) that can assemble to form homo- or heterotrimeric receptor complexes with distinct functional properties.

Upon activation by ATP, P2X receptors undergo conformational changes that allow for the flow of cations, such as calcium (Ca^2+^), sodium (Na^+^), and potassium (K^+^) ions, across the cell membrane. This ion flux can lead to a variety of downstream signaling events, including the activation of second messenger systems and changes in gene expression.

Purinergic P2X receptors have been implicated in a number of pathological conditions, including chronic pain, inflammation, and neurodegenerative diseases. As such, they are an active area of research for the development of novel therapeutic strategies.

Adenine nucleotides are molecules that consist of a nitrogenous base called adenine, which is linked to a sugar molecule (ribose in the case of adenosine monophosphate or AMP, and deoxyribose in the case of adenosine diphosphate or ADP and adenosine triphosphate or ATP) and one, two, or three phosphate groups. These molecules play a crucial role in energy transfer and metabolism within cells.

AMP contains one phosphate group, while ADP contains two phosphate groups, and ATP contains three phosphate groups. When a phosphate group is removed from ATP, energy is released, which can be used to power various cellular processes such as muscle contraction, nerve impulse transmission, and protein synthesis. The reverse reaction, in which a phosphate group is added back to ADP or AMP to form ATP, requires energy input and often involves the breakdown of nutrients such as glucose or fatty acids.

In addition to their role in energy metabolism, adenine nucleotides also serve as precursors for other important molecules, including DNA and RNA, coenzymes, and signaling molecules.

Nucleoside-phosphate kinase (NPK) is an enzyme that plays a crucial role in the synthesis and metabolism of nucleotides, which are the building blocks of DNA and RNA. NPK catalyzes the transfer of a phosphate group from a donor molecule, typically ATP, to a nucleoside or deoxynucleoside, forming a nucleoside monophosphate (NMP) or deoxynucleoside monophosphate (dNMP).

There are several isoforms of NPK found in different cellular compartments and tissues, each with distinct substrate specificities. These enzymes play essential roles in maintaining the balance of nucleotides required for various cellular processes, including DNA replication, repair, and transcription, as well as RNA synthesis and metabolism.

Abnormalities in NPK activity or expression have been implicated in several human diseases, such as cancer, viral infections, and neurological disorders. Therefore, understanding the function and regulation of NPK is crucial for developing novel therapeutic strategies to target these conditions.

Phosphotransferases are a group of enzymes that catalyze the transfer of a phosphate group from a donor molecule to an acceptor molecule. This reaction is essential for various cellular processes, including energy metabolism, signal transduction, and biosynthesis.

The systematic name for this group of enzymes is phosphotransferase, which is derived from the general reaction they catalyze: D-donor + A-acceptor = D-donor minus phosphate + A-phosphate. The donor molecule can be a variety of compounds, such as ATP or a phosphorylated protein, while the acceptor molecule is typically a compound that becomes phosphorylated during the reaction.

Phosphotransferases are classified into several subgroups based on the type of donor and acceptor molecules they act upon. For example, kinases are a subgroup of phosphotransferases that transfer a phosphate group from ATP to a protein or other organic compound. Phosphatases, another subgroup, remove phosphate groups from molecules by transferring them to water.

Overall, phosphotransferases play a critical role in regulating many cellular functions and are important targets for drug development in various diseases, including cancer and neurological disorders.

Suramin is a medication that has been used for the treatment of African sleeping sickness, which is caused by trypanosomes. It works as a reverse-specific protein kinase CK inhibitor and also blocks the attachment of the parasite to the host cells. Suramin is not absorbed well from the gastrointestinal tract and is administered intravenously.

It should be noted that Suramin is an experimental treatment for other conditions such as cancer, neurodegenerative diseases, viral infections and autoimmune diseases, but it's still under investigation and has not been approved by FDA for those uses.

Purinergic P2 receptors are a type of cell surface receptor that bind to purine nucleotides and nucleosides, such as ATP (adenosine triphosphate) and ADP (adenosine diphosphate), and mediate various physiological responses. These receptors are divided into two main families: P2X and P2Y.

P2X receptors are ionotropic receptors, meaning they form ion channels that allow the flow of ions across the cell membrane upon activation. There are seven subtypes of P2X receptors (P2X1-7), each with distinct functional and pharmacological properties.

P2Y receptors, on the other hand, are metabotropic receptors, meaning they activate intracellular signaling pathways through G proteins. There are eight subtypes of P2Y receptors (P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, P2Y13, and P2Y14), each with different G protein coupling specificities and downstream signaling pathways.

Purinergic P2 receptors are widely expressed in various tissues, including the nervous system, cardiovascular system, respiratory system, gastrointestinal tract, and immune system. They play important roles in regulating physiological functions such as neurotransmission, vasodilation, platelet aggregation, smooth muscle contraction, and inflammation. Dysregulation of purinergic P2 receptors has been implicated in various pathological conditions, including pain, ischemia, hypertension, atherosclerosis, and cancer.

Guanosine triphosphate (GTP) is a nucleotide that plays a crucial role in various cellular processes, such as protein synthesis, signal transduction, and regulation of enzymatic activities. It serves as an energy currency, similar to adenosine triphosphate (ATP), and undergoes hydrolysis to guanosine diphosphate (GDP) or guanosine monophosphate (GMP) to release energy required for these processes. GTP is also a precursor for the synthesis of other essential molecules, including RNA and certain signaling proteins. Additionally, it acts as a molecular switch in many intracellular signaling pathways by binding and activating specific GTPase proteins.

Adenosine Triphosphate (ATP) is a high-energy molecule that stores and transports energy within cells. It is the main source of energy for most cellular processes, including muscle contraction, nerve impulse transmission, and protein synthesis. ATP is composed of a base (adenine), a sugar (ribose), and three phosphate groups. The bonds between these phosphate groups contain a significant amount of energy, which can be released when the bond between the second and third phosphate group is broken, resulting in the formation of adenosine diphosphate (ADP) and inorganic phosphate. This process is known as hydrolysis and can be catalyzed by various enzymes to drive a wide range of cellular functions. ATP can also be regenerated from ADP through various metabolic pathways, such as oxidative phosphorylation or substrate-level phosphorylation, allowing for the continuous supply of energy to cells.

E.coli are shown to be more sensitive to accumulations of guanosine tetraphosphate than guanosine pentaphosphate. A complete ... p)ppGpp, guanosine pentaphosphate and tetraphosphate, also known as the "magic spot" nucleotides, are alarmones involved in the ... Kuroda, Akio; Murphy, Helen; Cashel, Michael; Kornberg, Arthur (1997-08-22). "Guanosine Tetra- and Pentaphosphate Promote ...
"Structural Characterization of the Stringent Response Related Exopolyphosphate/Guanosine Pentaphosphate Phosphohydrolase ...
Haseltine WA, Block R (May 1973). "Synthesis of guanosine tetra- and pentaphosphate requires the presence of a codon-specific, ...
"Synthesis of guanosine tetra- and pentaphosphate requires the presence of a codon-specific, uncharged transfer ribonucleic acid ...
Haseltine, WA; Block R (1974). "Synthesis of Guanosine Tetra- and Penta-phosphate Requires the Presence of Codon Specific ...
... guanosine pentaphosphate ((p)ppGpp), and cyclic di-GMP (c-di-GMP). c-di-AMP is a signaling nucleotide used in signaling ... It is one of many ubiquitous nucleotide second messengers including cyclic adenosine monophosphate (cAMP), cyclic guanosine ...
... guanosine pentaphosphate phosphatase, guanosine 5'-triphosphate 3'-diphosphate 5'-phosphatase, and guanosine pentaphosphate ... guanosine 5'-diphosphate,3'-diphosphate + phosphate Thus, the two substrates of this enzyme are guanosine 5'-triphosphate,3'- ... In enzymology, a guanosine-5'-triphosphate,3'-diphosphate diphosphatase (EC 3.6.1.40) is an enzyme that catalyzes the chemical ... The systematic name of this enzyme class is guanosine-5'-triphosphate,3'-diphosphate 5'-phosphohydrolase. Other names in common ...
... the ribosome will stall and trigger the synthesis of the guanosine pentaphosphate ((p)ppGpp) molecule. (p)ppGpp biosynthesis is ... NDPK are involved in the synthesis of nucleoside triphosphates (NTP), such as guanosine triphosphate (GTP), cytidine ... when guanosine triphosphate (GTP) produced in the citric acid (Krebs) cycle is converted to adenosine triphosphate (ATP). Other ...
... guanosine 5',3'-polyphosphate synthetase, (p)ppGpp synthetase I, (p)ppGpp synthetase II, guanosine pentaphosphate synthetase, ... Other names in common use include stringent factor, guanosine 3',5'-polyphosphate synthase, GTP pyrophosphokinase, ATP-GTP 3'- ... Sy J, Akers H (1976). "Purification and properties of guanosine 5', 3'-polyphosphate synthetase from Bacillus brevis". ... guanosine 3'-diphosphate 5'-triphosphate Thus, the two substrates of this enzyme are ATP and GTP, whereas its two products are ...
... guanosine diphosphate mannose MeSH D13.695.667.454.440 - guanosine pentaphosphate MeSH D13.695.667.454.480 - guanosine ... guanosine diphosphate mannose MeSH D13.695.827.426.440 - guanosine pentaphosphate MeSH D13.695.827.426.480 - guanosine ... guanosine diphosphate MeSH D13.695.667.454.340.350 - guanosine diphosphate sugars MeSH D13.695.667.454.340.350.400 - guanosine ... guanosine diphosphate MeSH D13.695.827.426.340.350 - guanosine diphosphate sugars MeSH D13.695.827.426.340.350.400 - guanosine ...
E.coli are shown to be more sensitive to accumulations of guanosine tetraphosphate than guanosine pentaphosphate. A complete ... p)ppGpp, guanosine pentaphosphate and tetraphosphate, also known as the "magic spot" nucleotides, are alarmones involved in the ... Kuroda, Akio; Murphy, Helen; Cashel, Michael; Kornberg, Arthur (1997-08-22). "Guanosine Tetra- and Pentaphosphate Promote ...
guanosine pentaphosphate synthetase I/polyribonucleotide nucleotidyltransferase YP_003635154 normal 1 normal 1 Cellulomonas ...
guanosine pentaphosphate synthetase I/polyribonucleotide nucleotidyltransferase (TIGR02696; EC 2.7.-.-,2.7.7.8; HMM-score: 58.7 ...
The second messengers guanosine tetraphosphate and pentaphosphate [(p)ppGpp] have a profound impact on the long-term survival, ... Introduction: The guanine nucleotide pool (GTP, guanosine-5-triphosphate; GDP, guanosine-5-diphosphate, and GMP, guanosine-5 ... The alarmone nucleotides guanosine tetraphosphate and pentaphosphate, commonly referred to as (p)ppGpp, regulate bacterial ... The stringent response is a stress signalling system mediated by the alarmones guanosine tetraphosphate (ppGpp) and guanosine ...
Methods Preparation of guanosine tetraphosphate (ppGpp) and guanosine pentaphosphate (pppGpp) from Escherichia coli displays ...
Preparation of guanosine tetraphosphate (ppGpp) and guanosine pentaphosphate (pppGpp) from Escherichia coli, for example) show ...
Mark Structural characterization of the stringent response related exopolyphosphatase/guanosine pentaphosphate phosphohydrolase ...
Methods Preparation of guanosine tetraphosphate (ppGpp) and guanosine pentaphosphate (pppGpp) from Escherichia coli into an ...
3-Diphosphate 5-Triphosphate, Guanosine use Guanosine Pentaphosphate 3-Diphosphate, Guanosine 5-Diphosphate use Guanosine ... 3,5-Monophosphate, Guanosine Cyclic use Cyclic GMP 3,5-Nucleotide Phosphodiesterase use 3,5-Cyclic-AMP Phosphodiesterases ...
3-Diphosphate 5-Triphosphate, Guanosine use Guanosine Pentaphosphate 3-Diphosphate, Guanosine 5-Diphosphate use Guanosine ... 3,5-Monophosphate, Guanosine Cyclic use Cyclic GMP 3,5-Nucleotide Phosphodiesterase use 3,5-Cyclic-AMP Phosphodiesterases ...
3-Diphosphate 5-Triphosphate, Guanosine use Guanosine Pentaphosphate 3-Diphosphate, Guanosine 5-Diphosphate use Guanosine ... 3,5-Monophosphate, Guanosine Cyclic use Cyclic GMP 3,5-Nucleotide Phosphodiesterase use 3,5-Cyclic-AMP Phosphodiesterases ...
Polynucleotide phosphorylase/guanosine pentaphosphate synthase (PNPase/GPSI), domain 3. 6.15e-24 ...
Guanosine Diphosphate. *Guanosine Monophosphate. *Guanosine Pentaphosphate. *Guanosine Tetraphosphate. *Guanosine Triphosphate ... "Guanosine Monophosphate" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical ... This graph shows the total number of publications written about "Guanosine Monophosphate" by people in this website by year, ... Below are the most recent publications written about "Guanosine Monophosphate" by people in Profiles. ...
Guanosine Monophosphate D3.438.759.646.454.525 D3.633.100.759.646.454.525 Guanosine Pentaphosphate D3.438.759.646.454.440 ... Guanosine D3.438.759.590.454 D3.633.100.759.590.454 Guanosine Diphosphate D3.438.759.646.454.340 D3.633.100.759.646.454.340 ... Guanosine Diphosphate Mannose D3.438.759.646.454.340.350.500 D3.633.100.759.646.454.340.350.500 Guanosine Diphosphate Sugars ... D3.633.100.759.646.454.440 Guanosine Tetraphosphate D3.438.759.646.454.480 D3.633.100.759.646.454.480 Guanosine Triphosphate ...
Guanosine Monophosphate D3.438.759.646.454.525 D3.633.100.759.646.454.525 Guanosine Pentaphosphate D3.438.759.646.454.440 ... Guanosine D3.438.759.590.454 D3.633.100.759.590.454 Guanosine Diphosphate D3.438.759.646.454.340 D3.633.100.759.646.454.340 ... Guanosine Diphosphate Mannose D3.438.759.646.454.340.350.500 D3.633.100.759.646.454.340.350.500 Guanosine Diphosphate Sugars ... D3.633.100.759.646.454.440 Guanosine Tetraphosphate D3.438.759.646.454.480 D3.633.100.759.646.454.480 Guanosine Triphosphate ...
m7GMP-α-F. Synonyms: (m7GpF); 7-methyl-guanosine-5-(α-fluoro)-monophosphate; 7-methyl-guanosine-5-(1-fluoro)-monophosphate. ... Synonyms: P; -(5-7-Methyl-Guanosyl)-P; -(5-Guanosyl)-pentaphosphate, Sodium salt. Grades: Laboratory chemicals, Lab Reagent ... Synonyms: 7-Methyl-guanosine-5-triphosphate, Sodium salt. Grades: Lab chemicals, Laboratory Reagents Grade. CAS No. 26554-26-7 ... Synonyms: 7-methyl-guanosine-5-monophosphate, triethylammonium salt. Grades: Lab chemicals, Laboratory Reagents Grade. CAS No ...
scientific article published on 11 October 2011
Guanosine Diphosphate. *Guanosine Monophosphate. *Guanosine Pentaphosphate. *Guanosine Tetraphosphate. *Guanosine Triphosphate ... Guanosine cyclic 3,5-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the ...
Guanosine 5-monophosphate (GMP) * Guanosine 5-triphosphate (GTP) * Guanosine diphosphate (GDP) * Guanosine monophosphate (GMP ...
P¹, P⁵- Di- (inosine- 5)- pentaphosphate ( Ip₅I ), sodium salt. Cat. No.: D 160. CAS No.: [1294478-76-4]. Technical ... J. Pharmacol., 128, 981 - 988 (1999), "Diinosine Pentaphosphate (IP5I) is a Potent Antagonist at Recombinant Rat P2X1 Receptors ... J. Pharmacol., 130, 1378 - 1384 (2000), "Diinosine Pentaphosphate: an Antagonist which Discriminates between Recombinant P2X3 ... Guanosine Analogues * Inosine Analogues * Purine Nucleosides * Miscellaneous * Nucleoside-2, 3 & 5-monophosphates * 2-O- ...
PENTAPHOSPHATE , UNKNOWN FUNCTION, ADP/ATP-DEPENDENT NAD(P)H-HYDRATE DEHYDRATASE, LYASE 1c3q:A (ALA118) to (THR236) CRYSTAL ... CRYSTAL STRUCTURE OF PROBABLE SUGAR KINASE PROTEIN FROM RHIZOBIUM ETLI CFN 42 COMPLEXED WITH GUANOSINE , STRUCTURAL GENOMICS, ... CRYSTAL STRUCTURE OF PROBABLE SUGAR KINASE PROTEIN FROM RHIZOBIUM ETLI CFN 42 COMPLEXED WITH GUANOSINE , STRUCTURAL GENOMICS, ...
Timeline for Species Streptomyces antibioticus [TaxId:1890] from d.52.3.1 Polynucleotide phosphorylase/guanosine pentaphosphate ... Species Streptomyces antibioticus [TaxId:1890] from d.52.3.1 Polynucleotide phosphorylase/guanosine pentaphosphate synthase ( ... Species Streptomyces antibioticus [TaxId:1890] from d.52.3.1 Polynucleotide phosphorylase/guanosine pentaphosphate synthase ( ... Species Streptomyces antibioticus [TaxId:1890] from d.52.3.1 Polynucleotide phosphorylase/guanosine pentaphosphate synthase ( ...
Guanosine tetra- and pentaphosphate increase antibiotic tolerance by reducing reactive oxygen species production in Vibrio ...
Guanosine Pentaphosphate Entry term(s). (p)ppGpp 3-Diphosphate 5-Triphosphate, Guanosine 5-Triphosphate, Guanosine 3- ... Guanosine pentaphosphate Entry term(s):. (p)ppGpp. 3-Diphosphate 5-Triphosphate, Guanosine. 5-Triphosphate, Guanosine 3- ... Guanosine 3 Diphosphate 5 Triphosphate Guanosine 3-Diphosphate 5-Triphosphate Pentaphosphate, Guanosine pppGpp, Alarmone ... Guanosine 3 Diphosphate 5 Triphosphate. Guanosine 3-Diphosphate 5-Triphosphate. Pentaphosphate, Guanosine. pppGpp, Alarmone ...
Guanosine Pentaphosphate Preferred Concept UI. M0009692. Registry Number. 38918-96-6. Scope Note. Guanosine 5-triphosphate 2( ... Guanosine Pentaphosphate Preferred Term Term UI T018688. Date01/01/1999. LexicalTag NON. ThesaurusID NLM (1978). ... Guanosine Pentaphosphate. Tree Number(s). D03.633.100.759.646.454.440. D13.695.667.454.440. D13.695.827.426.440. Unique ID. ... Guanosine 3-Diphosphate 5-Triphosphate ppprGpp Registry Number. 38918-96-6. CAS Type 1 Name. Guanosine 5-(tetrahydrogen ...
Guanosine Pentaphosphate Preferred Concept UI. M0009692. Registry Number. 38918-96-6. Scope Note. Guanosine 5-triphosphate 2( ... Guanosine Pentaphosphate Preferred Term Term UI T018688. Date01/01/1999. LexicalTag NON. ThesaurusID NLM (1978). ... Guanosine Pentaphosphate. Tree Number(s). D03.633.100.759.646.454.440. D13.695.667.454.440. D13.695.827.426.440. Unique ID. ... Guanosine 3-Diphosphate 5-Triphosphate ppprGpp Registry Number. 38918-96-6. CAS Type 1 Name. Guanosine 5-(tetrahydrogen ...
Guanosine-5-triphosphate,3-diphosphate pyrophosphatase Current Synonym true false 210313010 Guanosine pentaphosphate ... Guanosine-5-triphosphate,3-diphosphate pyrophosphatase (substance). Code System Preferred Concept Name. Guanosine-5- ...
... guanosine pentaphosphate,noun,E0504861,yes di,diguanosine tetraphosphate,noun,E0529215,guanosine tetraphosphate,noun,E0504360, ... yes di,diguanosine triphosphate,noun,E0529216,guanosine triphosphate,noun,E0030522,yes di,diguanylate cyclase,noun,E0521484, ...
guanosine pentaphosphate phosphohydrolase (gppA). 4e-13. 75.5. NC_009665:4675289:4695638. 4695638. 4696564. 927. Shewanella ... guanosine pentaphosphate phosphohydrolase. 3e-13. 75.9. NC_013960:2366910:2368637. 2368637. 2370145. 1509. Nitrosococcus ... guanosine pentaphosphate phosphohydrolase. 8e-12. 71.2. NC_016001:1893685:1895778. 1895778. 1896683. 906. Flavobacterium ... Guanosine-5-triphosphate,3-diphosphate diphosphatase. 3e-13. 75.9. NC_009850:1822239:1824917. 1824917. 1826386. 1470. ...
guanosine pentaphosphate biosynthetic process GO:0015973 * coenzyme A biosynthetic process GO:0015937 ...
Manoil C., Kaiser D. 1980; Guanosine pentaphosphate and guanosine tetraphosphate accumulation and induction of Myxococcus ...
Pattern Recognition N0000179713 iron pentacarbonyl N0000170840 Guanosine Pentaphosphate N0000171321 Dipeptidyl Peptidase 4 ... Hydroxyl-Kinase N0000170852 Guanosine 5-O-(3-Thiotriphosphate) N0000169019 Arachidonate 5-Lipoxygenase N0000170029 Camphor 5- ... Dehydrogenase N0000170779 Uridine Diphosphate Glucuronic Acid N0000183503 Nucleoside Diphosphate Kinase D N0000170844 Guanosine ... Diphosphate Ribose N0000170778 Uridine Diphosphate Sugars N0000170812 Adenosine Diphosphate Sugars N0000170843 Guanosine ...
... "guanosine pentaphosphate phosphohydrolase [Ensembl]. Ppx/GppA phosphatase family [InterProScan].","protein_coding" "AGT26590"," ... guanosine pentaphosphate synthetase + polyribonucleotide nucleotidyltransferase (polynucleotide phosphorylase) (pnpase) [ ... ","inosine-guanosine kinase [Ensembl]. pfkB family carbohydrate kinase [Interproscan].","protein_coding" "AAL19584","STM0633"," ... ","guanosine-3,5-bis 3-pyrophosphohydrolase [Ensembl].","protein_coding" "EDJ91290","rpoZ","Haemophilus influenzae","DNA- ...
... was guanosine pentaphosphate (pppGpp) hydrolase (20), the en- zyme that produces guanosine tetraphosphate (ppGpp; "magic spot ... Guanosine pentaphos- phate phosphohydrolase of Escherichia coli is a long-chain exopolyphos- phatase. Proc. Natl. Acad. Sci. ...
Preparation of guanosine tetraphosphate (ppGpp) and guanosine pentaphosphate (pppGpp) from Escherichia coli displays high ...
Synthesis of guanosine tetra- and pentaphosphate requires the presence of a codon-specific, uncharged transfer ribonucleic acid ...
... guanosine tetra- and pentaphosphate) production, which activates the stringent response and subsequent downstream functional ...
... guanosine pentaphosphate,noun,E0504861,yes di,diguanosine tetraphosphate,noun,E0529215,guanosine tetraphosphate,noun,E0504360, ... yes di,diguanosine triphosphate,noun,E0529216,guanosine triphosphate,noun,E0030522,yes di,diguanylate cyclase,noun,E0521484, ...
Guanosine Monophosphate D3.438.759.646.454.525 D3.633.100.759.646.454.525 Guanosine Pentaphosphate D3.438.759.646.454.440 ... Guanosine D3.438.759.590.454 D3.633.100.759.590.454 Guanosine Diphosphate D3.438.759.646.454.340 D3.633.100.759.646.454.340 ... Guanosine Diphosphate Mannose D3.438.759.646.454.340.350.500 D3.633.100.759.646.454.340.350.500 Guanosine Diphosphate Sugars ... D3.633.100.759.646.454.440 Guanosine Tetraphosphate D3.438.759.646.454.480 D3.633.100.759.646.454.480 Guanosine Triphosphate ...
D3.438.759.646.454.340.350.500 Guanosine Diphosphate Sugars D3.438.759.646.454.340.350 Guanosine Pentaphosphate D3.438.759.646. ... D3.438.759.646.454 Guanosine D3.438.759.590.454 Guanosine Diphosphate D3.438.759.646.454.340 Guanosine Diphosphate Fucose ... 454.440 Guanosine Tetraphosphate D3.438.759.646.454.480 Guanosine Triphosphate D3.438.759.646.454.504 Guanylyl Imidodiphosphate ... D3.438.759.646.454.340.350.400 Guanosine Diphosphate Mannose ...
Guanosine Monophosphate D3.438.759.646.454.525 D3.633.100.759.646.454.525 Guanosine Pentaphosphate D3.438.759.646.454.440 ... Guanosine D3.438.759.590.454 D3.633.100.759.590.454 Guanosine Diphosphate D3.438.759.646.454.340 D3.633.100.759.646.454.340 ... Guanosine Diphosphate Mannose D3.438.759.646.454.340.350.500 D3.633.100.759.646.454.340.350.500 Guanosine Diphosphate Sugars ... D3.633.100.759.646.454.440 Guanosine Tetraphosphate D3.438.759.646.454.480 D3.633.100.759.646.454.480 Guanosine Triphosphate ...
Guanosine Monophosphate D3.438.759.646.454.525 D3.633.100.759.646.454.525 Guanosine Pentaphosphate D3.438.759.646.454.440 ... Guanosine D3.438.759.590.454 D3.633.100.759.590.454 Guanosine Diphosphate D3.438.759.646.454.340 D3.633.100.759.646.454.340 ... Guanosine Diphosphate Mannose D3.438.759.646.454.340.350.500 D3.633.100.759.646.454.340.350.500 Guanosine Diphosphate Sugars ... D3.633.100.759.646.454.440 Guanosine Tetraphosphate D3.438.759.646.454.480 D3.633.100.759.646.454.480 Guanosine Triphosphate ...
Guanosine Monophosphate D3.438.759.646.454.525 D3.633.100.759.646.454.525 Guanosine Pentaphosphate D3.438.759.646.454.440 ... Guanosine D3.438.759.590.454 D3.633.100.759.590.454 Guanosine Diphosphate D3.438.759.646.454.340 D3.633.100.759.646.454.340 ... Guanosine Diphosphate Mannose D3.438.759.646.454.340.350.500 D3.633.100.759.646.454.340.350.500 Guanosine Diphosphate Sugars ... D3.633.100.759.646.454.440 Guanosine Tetraphosphate D3.438.759.646.454.480 D3.633.100.759.646.454.480 Guanosine Triphosphate ...
  • p)ppGpp, guanosine pentaphosphate and tetraphosphate, also known as the "magic spot" nucleotides, are alarmones involved in the stringent response in bacteria that cause the inhibition of RNA synthesis when there is a shortage of amino acids. (wikipedia.org)
  • E.coli are shown to be more sensitive to accumulations of guanosine tetraphosphate than guanosine pentaphosphate. (wikipedia.org)
  • Methods Preparation of guanosine tetraphosphate (ppGpp) and guanosine pentaphosphate (pppGpp) from Escherichia coli displays high catalase activity: an additional cleanup using the Procreate app. (theoldrailwayshop.com)
  • GDP, guanosine-5'-diphosphate, and GMP, guanosine-5'-monophosphate) is an essential energy donor in various biological processes (eg protein synthesis and gluconeogenesis) and secures several vital regulatory functions in the human body. (bvsalud.org)
  • Guanosine Monophosphate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (uchicago.edu)
  • This graph shows the total number of publications written about "Guanosine Monophosphate" by people in this website by year, and whether "Guanosine Monophosphate" was a major or minor topic of these publications. (uchicago.edu)
  • Below are the most recent publications written about "Guanosine Monophosphate" by people in Profiles. (uchicago.edu)
  • Results: The concentration of erythrocyte GTP and total guanine nucleotides (TGN) were highest in the SP group, lower in the EN group, and lowest in the CO group. (bvsalud.org)
  • Guanosine Monophosphate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (uchicago.edu)
  • This graph shows the total number of publications written about "Guanosine Monophosphate" by people in this website by year, and whether "Guanosine Monophosphate" was a major or minor topic of these publications. (uchicago.edu)
  • Below are the most recent publications written about "Guanosine Monophosphate" by people in Profiles. (uchicago.edu)